The 2026 Diagnostic Shift: How Automated Immunoassays are Transforming Syphilis Detection
The clinical landscape of 2026 is witnessing a monumental shift in how infectious diseases are managed at the laboratory level. As syphilis rates reach decadal highs in several developed nations, the reliance on manual, labor-intensive screening is fading. Modern laboratories are now integrating high-throughput, fully automated platforms that utilize chemiluminescence immunoassay (CLIA)...
0 Comments 0 Shares 590 Views 0 Reviews